CVS Health Corp (NYSE:CVS) shares, rose in value, with the stock price up by 1.81% to the previous day’s close as strong demand from buyers drove the stock to $62.45.
Actively observing the price movement in the last trading, the stock closed the session at $61.34. The PE ratio was 14.92 over 12-month period. Referring to stock’s 52-week performance, its high was $72.51, and the low was $43.56. On the whole, CVS has fluctuated by -3.82% over the past month.
With the market capitalization of CVS Health Corp currently standing at about $79.00 billion, investors are eagerly awaiting this quarter’s results, scheduled for in June. The company’s Forward Dividend Ratio is 2.66, with its dividend yield at 4.26%.
Technical indicators serve as essential tools for traders, offering insights into market sentiment and potential price movements. We see that CVS’s technical picture suggests that short-term indicators denote the stock is a Hold on average. However, medium-term indicators have put the stock in the category of 50% Buy while long-term indicators on average have been pointing out that it is a 100% Buy.
The stock’s technical analysis shows that the PEG ratio is about 1.08, with the price of CVS currently trading nearly -2.45% and -5.21% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 45.38, while the 7-day volatility ratio is showing 2.19% which for the 30-day chart, stands at 2.63%. Furthermore, CVS Health Corp (CVS)’s beta value is 0.54, and its average true range (ATR) is 2.03.
A comparison of CVS Health Corp (CVS) with its peers suggests the former has fared considerably weaker in the market. CVS showed an intraday change of 1.81% in last session, and over the past year, it grew by 12.22%%.
Data on historical trading for CVS Health Corp (NYSE:CVS) indicates that the trading volumes over the past 3 months, they’ve averaged 10.29 million. According to company’s latest data on outstanding shares, there are 1.27 billion shares outstanding.
Nearly 0.15% of CVS Health Corp’s shares belong to company insiders and institutional investors own 86.72% of the company’s shares. The stock has risen by 39.12% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the CVS stock heading into the next quarter.
